Alendronate sodium

Alendronate sodium

• No risk of nitrozamines presence
• Extensive experience with commercial manufacturing
• In house production of the whole product family (Risedronate, Zoledronate, Ibandronate)

Status	Commercial
Therapeutic cat.	Musculo-skeletal
Polymorphic form	Trihydrate
CAS No.	121268-17-5
Injectable Form	Injectable
EU DMF readiness
CEP
CHINESE  DMF
JAPANESE DMF
KOREAN  DMF
CANADIAN  DMF
CADIFA
US DMF readiness

Drug description

Alendronate is used to treat osteoporosis caused by menopause, steroid use, or gonadal failure. alendronate is for use when you have a high risk of bone fracture due to osteoporosis. Alendronate is also used to treat Paget's disease of bone. Alendronate may also be used for purposes not listed in this medication guide.

Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).